Beauty Comparison

Fungal Nail Infection: Signs, Causes, Treatment & Prevention

Reviewed June 2026 8 min read 5 sources

The short answer

A fungal nail infection (onychomycosis) thickens, discolors, and crumbles the nail.

What Is a Fungal Nail Infection?

A fungal nail infection — medically called onychomycosis or tinea unguium — is an infection of the nail plate (and often the nail bed beneath it) by pathogenic fungi. It is the single most common nail disorder worldwide, accounting for more than 50% of all nail disease presenting to dermatologists, with a global prevalence estimated at around 5.5%.

Toenails are affected far more often than fingernails, in a ratio of roughly 4:1, because footwear creates a warm, dark, humid environment in which fungi thrive. The infection is not merely cosmetic: severe onychomycosis can cause pain during walking, impair balance in older adults, and serve as a portal of entry for secondary bacterial infection — a particularly serious concern in people with diabetes or peripheral vascular disease.


What Causes Fungal Nail Infections?

Three groups of fungi cause onychomycosis:

1. Dermatophytes (~70% of cases) The most frequent culprit is Trichophyton rubrum, a dermatophyte that also causes athlete's foot (tinea pedis). T. mentagrophytes and Epidermophyton floccosum are other common dermatophyte species. Dermatophytes are uniquely adapted to digest keratin — the protein that makes up the nail plate — allowing them to invade and colonize nail tissue.

2. Non-dermatophyte moulds (~20% of cases) Moulds such as Scopulariopsis brevicaulis, Fusarium species, and Aspergillus species can also infect nails, particularly in people with prior nail damage. Identifying these organisms matters because some are resistant to terbinafine and require different treatment.

3. Yeasts (~10–20% of cases) Candida species more commonly infect fingernails than toenails, especially in people who have frequent hand-water exposure (dishwashers, healthcare workers, domestic workers) or immunosuppression. Candida nail infection often co-occurs with paronychia — inflammation of the surrounding nail fold.

How Does Infection Spread?

Fungal spores survive for months in warm, moist environments — shower floors, pool surrounds, locker rooms, yoga mats, and the insides of old shoes. Most toenail infections begin as athlete's foot on the surrounding skin; the fungus then invades the nail from its free edge or lateral margins. Sharing nail clippers or nail files with an infected person can also transmit infection.


Risk Factors

Not everyone who walks barefoot in a gym locker room develops onychomycosis. Several factors increase susceptibility:

  • Older age — prevalence rises sharply with age; those over 60 have a significantly higher risk than younger adults
  • Male sex — men are affected roughly twice as often as women
  • Tinea pedis — athlete's foot is the single strongest predisposing factor for toenail onychomycosis
  • Diabetes mellitus — impaired immunity and circulation
  • Peripheral vascular disease — poor blood flow to the feet
  • Immunosuppression — HIV, organ transplant medications, chemotherapy
  • Psoriasis — structural changes in the nail plate create points of entry
  • Hyperhidrosis (excessive sweating) — a persistently moist nail environment
  • Nail trauma — from tight shoes, sport, or repetitive microtrauma

Symptoms: What Does a Fungal Nail Infection Look Like?

Onychomycosis has a gradual onset — most people notice the nail changing over months before seeking help. The classic presentation includes:

Distal and Lateral Subungual Onychomycosis (DLSO) — most common type

  • Yellow, brown, or white discoloration starting at the nail's free edge or sides
  • Subungual hyperkeratosis — a build-up of crumbly debris under the nail plate, causing the nail to lift away from the nail bed (onycholysis)
  • Nail thickening and distortion
  • Nail brittleness — the nail crumbles or breaks easily

Superficial White Onychomycosis (SWO)

  • Flaky, chalky white patches on the surface of the nail plate
  • Caused most often by T. mentagrophytes or non-dermatophyte moulds
  • Can superficially resemble nail cosmetic damage

Proximal Subungual Onychomycosis (PSO)

  • Infection begins at the nail fold near the cuticle and spreads distally under the nail
  • Uncommon in immunocompetent individuals; strongly associated with HIV infection

Total Dystrophic Onychomycosis

  • End-stage disease: the entire nail plate is destroyed and replaced by crumbling, thickened debris
  • May result from any of the above forms if left untreated

What Onychomycosis Is NOT

Several conditions cause nail changes that look like fungal infection — including nail psoriasis, lichen planus of the nail, and simple nail trauma. This is precisely why laboratory confirmation matters before starting oral antifungal drugs.


Diagnosis: Why You Should Confirm Before Treating

Before starting oral antifungals — which require liver monitoring and have drug interaction potential — a clinician should confirm the diagnosis with:

  • KOH (potassium hydroxide) microscopy: A nail scraping is dissolved in KOH and examined under a microscope for fungal hyphae. Rapid and inexpensive, but can miss infection if sampling is inadequate.
  • Fungal culture: Identifies the specific organism and its antifungal sensitivities. Takes 2–4 weeks. Critical if a non-dermatophyte mould or Candida is suspected.
  • Nail plate histopathology (PAS stain): Examines nail clippings embedded in wax; high sensitivity.
  • PCR: Rapid molecular test with the highest sensitivity; increasingly available in specialist centers.

Up to 50% of abnormal-looking nails sent for culture in some series do not have confirmed fungal infection — underlining why laboratory testing before systemic treatment is the clinical standard.


Treatment Options

Oral Antifungals — First-Line for Moderate-to-Severe Disease

Terbinafine (250 mg daily) The gold-standard oral therapy. It works by inhibiting squalene epoxidase — a fungal enzyme essential for ergosterol synthesis — and reaches fungicidal concentrations in the nail plate that persist long after the course ends. Standard course: 12 weeks for toenails, 6 weeks for fingernails. Mycological cure rates for dermatophyte infections: approximately 70–80%. Adverse effects are generally mild (gastrointestinal upset, headache, taste disturbance) but rare serious hepatotoxicity means baseline and on-treatment liver function tests are advisable.

Itraconazole An azole antifungal used as an alternative when terbinafine is contraindicated or for non-dermatophyte mould infections. Can be given as continuous dosing (200 mg daily for 12 weeks) or pulse dosing (400 mg daily for one week per month for three months). More drug interactions than terbinafine.

Fluconazole Less commonly used and less effective; sometimes used for Candida nail infections.

Topical Antifungals — Suitable for Mild-to-Moderate or Limited Disease

Three FDA-approved topical options exist:

Product Active ingredient How applied Cure rate (mild-mod)
Jublia Efinaconazole 10% solution Daily to nail ~18% complete cure at 52 weeks
Kerydin Tavaborole 5% solution Daily to nail ~7–9% complete cure at 52 weeks
Penlac Ciclopirox 8% lacquer Daily (remove weekly) ~6–12% complete cure at 48 weeks

Complete cure rates for topical therapies appear modest because "complete cure" requires both mycological and clinical clearance simultaneously; mycological (lab) cure rates are considerably higher. Topical treatment requires patient commitment — typically 48–52 weeks of daily application — and is most appropriate when fewer than three nails are affected and involvement does not extend to the nail matrix (lunula).

Combination Therapy

Evidence supports combining oral terbinafine with a topical agent (particularly efinaconazole) to improve complete cure rates, especially in patients with difficult-to-treat infections, thick nails, or dermatophytomas (fungal balls embedded in the nail).

Nail Debridement

Regular mechanical or chemical nail debridement (thinning the nail plate) by a podiatrist or clinician reduces the fungal burden and improves penetration of topical treatments. It is an adjunct, not a standalone cure.

Device-Based Therapies (Evidence Limited)

Laser devices and photodynamic therapy have been studied but current evidence does not support them as standard-of-care treatments. The AAD does not recommend them as first-line options.


How Long Does Treatment Take?

Treatment is slow because antifungal drugs do not "push out" the infected nail — they prevent new nail growing in from the matrix from becoming infected. The visible nail itself must grow out and be clipped away. Toenails grow approximately 1–1.5 mm per month; a big toenail may take 12–18 months to fully clear even after the course of antifungals is finished. It is normal for the nail to look unchanged — or even worse — during the first 1–2 months of treatment.


Prevention: Stopping Reinfection

Recurrence rates for onychomycosis are high — reported at 20–25% within one year — largely because the source of infection (athlete's foot on the skin, contaminated footwear) is not addressed. To prevent reinfection:

  • Treat any concurrent athlete's foot with a topical antifungal (terbinafine cream, clotrimazole) until fully clear
  • Disinfect or replace old footwear — fungi can survive in shoes for months
  • Use antifungal foot powder inside shoes daily
  • Wear moisture-wicking socks and change them if damp
  • Avoid walking barefoot in communal showers, pool surrounds, and locker rooms — wear flip-flops
  • Keep nails trimmed short and dry
  • Use separate nail clippers for infected and uninfected nails; disinfect clippers with alcohol between uses
  • Dry feet carefully after bathing, especially between the toes

Onychomycosis in People with Diabetes

People with diabetes face a threefold higher prevalence of onychomycosis and are at elevated risk of serious complications, including secondary bacterial cellulitis from nail-related skin breaks. Oral antifungal therapy is generally recommended rather than topical therapy alone for diabetic patients with onychomycosis, but drug interactions with diabetes medications and the need for liver monitoring require close prescriber oversight. A podiatrist familiar with diabetic foot care should be part of the management team.


When to See a Professional

See your GP, dermatologist, or podiatrist if:

  • You notice nail thickening, discoloration, crumbling, or lifting — especially affecting multiple nails
  • A nail has become painful or is causing difficulty walking
  • You have diabetes, peripheral vascular disease, or immunosuppression — do not delay
  • OTC antifungal treatments (nail lacquers) have not improved the nail after 3–6 months
  • You are unsure whether your nail change is fungal or another condition

Do not start oral antifungal tablets without a clinician's assessment and, ideally, laboratory confirmation of infection.

Products that fit: fungal acne (malassezia)

Picked by code from each product's full ingredient list.

Affiliate

Amazon UK prices as of 6 November 2026, 06:08 GMT; Amazon sets the final price at checkout.

See the full guide: Best Moisturizers for Fungal Acne →

When to see a professional

See a GP, dermatologist, or podiatrist if a nail becomes thickened, discolored, crumbly, or detached from the nail bed. Seek prompt assessment if you have diabetes, peripheral vascular disease, or immunosuppression, as complications including secondary bacterial infection are more likely. Do not start oral antifungal tablets without a clinician's assessment and, ideally, laboratory confirmation — other nail conditions (especially psoriasis) can look identical and require different treatment. If OTC topical treatments have not improved the nail after 3–6 months, professional evaluation is warranted.

Frequently asked questions

What is the most effective treatment for fungal nail infection in 2026?

Oral terbinafine remains the gold-standard first-line treatment for toenail dermatophyte onychomycosis. Taken at 250 mg daily for 12 weeks, it achieves mycological cure in approximately 70–80% of dermatophyte cases — higher than itraconazole and far higher than any topical agent used alone. For mild or limited disease, or where oral therapy is contraindicated, FDA-approved topical efinaconazole 10% solution (Jublia) has the strongest evidence among topical options. Combination oral plus topical therapy is increasingly used for difficult-to-treat or recurrent cases. A clinician should confirm the diagnosis with laboratory testing before prescribing systemic antifungals.

Can a fungal nail infection go away on its own without treatment?

Spontaneous resolution without treatment is very rare. Onychomycosis is a persistent infection that typically worsens over time, spreading to additional nails and, in some cases, causing complete nail destruction. Without treatment, the infected nail also remains a source of fungal spores that can reinfect the skin (causing athlete's foot) and spread to other people. Treatment is strongly recommended — particularly for anyone with diabetes, peripheral vascular disease, or other conditions that increase the risk of secondary complications.

How can I tell the difference between a fungal nail and nail psoriasis?

Both conditions cause nail thickening, discoloration, and lifting from the nail bed, making them visually difficult to distinguish. Nail psoriasis often also causes pitting (small dents in the nail surface), oil-drop discoloration (a salmon-pink patch), and accompanying skin psoriasis. A KOH microscopy test or nail culture can confirm or exclude fungal infection — this is why laboratory testing before treatment is recommended. Treating presumed fungal infection in a patient who actually has psoriasis exposes them to unnecessary medication.

Are over-the-counter antifungal nail treatments effective?

OTC nail lacquers containing ciclopirox (available in some countries without prescription) provide limited benefit for mild, superficial infection. Terbinafine cream applied to the nail surface is largely ineffective for nail plate infection because topical agents cannot penetrate the thick keratin in adequate concentrations. FDA-approved topical solutions (efinaconazole, tavaborole) require a prescription in the US. For anything beyond the most superficial or minimal infection, professional assessment and treatment — typically oral antifungal therapy — produces significantly better outcomes.

Why does it take so long to cure a fungal nail infection?

Antifungal drugs prevent new infected nail from growing in from the matrix; they do not reverse the damage to existing nail. The infected nail must physically grow out and be trimmed away over many months. Toenails grow only about 1–1.5 mm per month, so a fully grown-out, clear toenail can take 12–18 months — even after completing a successful 12-week course of terbinafine. This is normal and does not mean treatment has failed. Patience and adherence to the full course are essential.

Is a fungal nail infection contagious?

Yes. Dermatophyte fungi spread through direct contact with infected nail or skin, through contaminated surfaces (shower floors, nail clippers, socks), and through shared footwear. People with onychomycosis should avoid sharing nail tools, wear flip-flops in communal wet areas, and treat the infection to reduce the risk of transmitting it to household members or spreading it to their own uninfected nails. Treating concurrent athlete's foot is critical, as the skin infection is the most common source of nail reinfection.

Health information, not medical advice.

Beauty Comparison is an independent editorial publication. This page is researched and sourced to the authorities listed below, but it is general information — not a diagnosis or a substitute for personalised advice from a qualified doctor, dermatologist or pharmacist. If your symptoms are severe, spreading, painful, or not improving, see a healthcare professional.

Sources

  1. 01Fungal Nail Infections — DermNet — DermNet NZ, 2023-01-01. Onychomycosis comprises over 50% of all nail disease; global prevalence approximately 5.5%; causative organisms (dermatophytes ~75%, non-dermatophyte moulds, Candida); clinical subtypes including DLSO, SWO, PSO.
  2. 02Updated Perspectives on the Diagnosis and Management of Onychomycosis — PMC / NIH, 2022-09-01. Oral terbinafine is recommended first-line; FDA-approved topicals include efinaconazole 10%, tavaborole 5%, ciclopirox 8%; laboratory confirmation (KOH, culture, histopathology, PCR) required before systemic treatment.
  3. 03Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes — PMC / NIH, 2024-01-01. Oral terbinafine 250 mg daily for 12 weeks achieves mycological cure in approximately 70–80% of dermatophyte toenail infections; itraconazole is an alternative; combination therapy improves outcomes in difficult-to-treat cases.
  4. 04Onychomycosis: An Updated Review — PMC / NIH, 2020-09-01. T. rubrum is the most common dermatophyte cause; risk factors include diabetes, peripheral vascular disease, tinea pedis, older age, male sex, immunosuppression, hyperhidrosis; recurrence rates approximately 20–25% within one year.
  5. 05Paronychia — StatPearls, NCBI Bookshelf — NIH / NCBI, 2023-01-01. Candida nail infections frequently co-occur with paronychia, particularly in individuals with frequent hand-water exposure or immunosuppression.